Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Net Cash Flow: 2010-2021

Historic Net Cash Flow for Neurocrine Biosciences (NBIX) over the last 11 years, with Dec 2021 value amounting to $29.7 million.

  • Neurocrine Biosciences' Net Cash Flow rose 112.47% to $29.7 million in Q4 2021 from the same period last year, while for Dec 2021 it was $153.7 million, marking a year-over-year increase of 105.48%. This contributed to the annual value of -$18.1 million for FY2024, which is 52.10% down from last year.
  • Per Neurocrine Biosciences' latest filing, its Net Cash Flow stood at $29.7 million for Q4 2021, which was up 152.20% from -$56.9 million recorded in Q3 2021.
  • In the past 5 years, Neurocrine Biosciences' Net Cash Flow registered a high of $244.9 million during Q2 2017, and its lowest value of -$238.2 million during Q4 2020.
  • Over the past 3 years, Neurocrine Biosciences' median Net Cash Flow value was $20.4 million (recorded in 2019), while the average stood at $16.4 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first soared by 961.98% in 2019, then plummeted by 657.84% in 2021.
  • Over the past 5 years, Neurocrine Biosciences' Net Cash Flow (Quarterly) stood at -$13.2 million in 2017, then slumped by 308.50% to -$54.0 million in 2018, then fell by 4.26% to -$56.3 million in 2019, then plummeted by 323.09% to -$238.2 million in 2020, then surged by 112.47% to $29.7 million in 2021.
  • Its Net Cash Flow was $29.7 million in Q4 2021, compared to -$56.9 million in Q3 2021 and $15.4 million in Q2 2021.